GH Axis Blend
CJC-1295 (No DAC) + Ipamorelin
CJC/Ipa blend · GHRH + GHRP stack
GHRH analogue plus selective secretagogue — the classic synergistic GH-release pairing.
10 mg (5 + 5)
Ipamorelin
Also known as: NNC 26-0161 · Selective GH secretagogue
Growth Hormone Axis In stock Box of 10 vials 1 reference
The first selective growth-hormone secretagogue — GH release without cortisol or prolactin.
Available sizes
| SKU | Per vial | Pack | |
|---|---|---|---|
| IP5 | 5 mg | 10 vials / box | |
| IP10 | 10 mg | 10 vials / box |
Order Ipamorelin
Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.
Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.
Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that stimulates GH release through the ghrelin/GHS receptor. It was identified in a Novo Nordisk programme as the first GHRP-receptor agonist whose selectivity for GH matched that of GHRH itself.
In the defining study, ipamorelin released GH with potency and efficacy comparable to GHRP-6 in rat and swine models, but — unlike GHRP-2 and GHRP-6 — did not elevate ACTH or cortisol even at doses 200-fold above the ED50, and had no effect on FSH, LH, prolactin or TSH 1.
At a glance
- GHS-R agonist with no ACTH/cortisol/prolactin release reported
- Original pharmacology published in Eur J Endocrinol
- 5 mg and 10 mg vials; also in CJC and tesamorelin blends
Research use only. All products are sold strictly for laboratory research and development purposes. They are not intended for human or veterinary use, diagnosis, treatment, cure or prevention of any disease. Not for human consumption. Summaries above describe published findings in laboratory and clinical research models and do not constitute claims about this product.
- Form
- Lyophilized powder
- Purity
- HPLC-verified — Certificate of Analysis available on request
- Pack size
- Box of 10 vials
- Storage
- Lyophilized: −20 °C, protected from light (2–8 °C short-term). Reconstituted: 2–8 °C.
- Sequence
- Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Formula
- C38H49N9O5
- Mol. weight
- 711.9 g/mol
- CAS No.
- 170851-70-4
Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-61.
Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.
Related
Often ordered together
GH Axis Blend
Tesamorelin + Ipamorelin
Tesa/Ipa blend
Stabilised GHRH analogue paired with the selective GHS-R agonist.
10 mg (5 + 5)20 mg (10 + 10)
GH Axis
GHRP-2 Acetate
Pralmorelin · KP-102
Potent synthetic hexapeptide GH secretagogue, clinically used as a diagnostic agent.
5 mg
GH Axis
GHRP-6 Acetate
Growth hormone-releasing hexapeptide · SKF-110679
The original synthetic GH-releasing hexapeptide that led to the discovery of ghrelin.
5 mg10 mg